In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

2nd Induced Proximity-Based Drug Discovery Summit

May 10, 2022 - 08:00 AM - May 12, 05:00 PM
Hanson Wade
Wyndham Boston Beacon Hill
5 Blossom Street,

ZIP: 02114
Phone: (+1) 617 455 4188

Ticket Price: USD 2599.00 - USD 5097.00

Coming to Boston next May, the 2nd Induced Proximity-Based Drug Discovery Summit is the only industry and academic dedicated summit focused on exciting innovations and emerging case studies to establish novel strategies of identifying and optimizing drug design, physiological properties and therapeutic applications of induced proximity-based drugs.

This multidisciplinary summit will be gathering 100+ of the industry drug discovery leaders in large and small molecule disciplines to discuss how the phenomenon of induced proximity can be leveraged to precisely engineer biological outcomes such as post-translational modifications and degradation of high value targets in oncology and beyond.

With 25+ expert leaders from the likes of Amgen, Centrose Pharma, Stablix, Jerry Crabtree, and Amit Choudhary sharing their progress, don’t miss the chance to join the industry’s definitive in-person conference to make new connections and reconnect with your friends and colleagues.

Tickets    https://go.evvnt.com/969482-2?pid=1052
Brochure https://go.evvnt.com/969482-3?pid=1052

Drug Developer Pricing - Conference Only USD 2999.00
Drug Developer Pricing - Conference + 1 Workshop USD 3648.00
Drug Developer Pricing - Conference + 2 Workshops USD 4297.00
Academic Pricing - Conference Only USD 2599.00
Academic Pricing - Conference + 1 Workshop USD 3148.00
Academic Pricing - Conference + 2 Workshops USD 3697.00
Standard Pricing - Conference Only USD 3599.00
Standard Pricing - Conference + 1 Workshop USD 4348.00
Standard Pricing - Conference + 2 Workshops USD 5097.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Discovery

Speaker Details

Omid Vafa, CBO, Ancora Biotech, Ed Ha, Head of Chemistry & Bioconjugation, Angiex, Manish, Hudlikar Scientist, Chemistry & Bioconjugates, Angiex, Nancy K Pryer, CSO, Ambagon Therapeutics, Ryan Potts, Head of Induced Proximity Platform, Amgen, James Prudent, CEO, Centrose Pharma, Behnam Nabet, Assistant Professor, Fred Hutchinson Cancer Research Center, Greg Verdine, Co-Founder & CEO, Fog Pharma, Binghe Wang, Regents Professor and Georgia Research Alliance Eminent Scholar, Georgia State University, Amit Choudhary, Assistant Professor of Medicine, Harvard Medical School, Christina Woo, Associate Professor, Harvard University, Charles Lin, SVP Biology, Kronos Bio, Anthony Rullo, Assistant Professor, McMaster University, Kevin Foley, CSO, Ranok Therapeutics, Nan Ji, CEO, PAQ Therapeutics, Alun Bermingham, Senior Director Discovery Sciences, Revolution Medicines, Matthew Disney, Professor, Scripps Research, Scott A. Kanner, Co-founder & Head of Platform Development, Stablix, Tommaso Cupido, Assistant Faculty, St Jude Children’s Research Hospital, Jerry Crabtree, David Korn Professor, Stanford University Medical School, Jesse J. Chen, Co-Founder & CTO, Triana Biomedicines, Goutham Narla, Professor of Internal Medicine and Human Genetics, Division Chief of Genetic Medicine, The University of Michigan, Nate Hathaway, Associate Professor, The University of North Carolina at Chapel Hill, George M. Burslem, Assistant Professor, University of Pennsylvania, Katarina Pance, PhD Candidate (Jim Wells Lab), University of California, San Francisco, William Pomerantz, Associate Professor, University of Minnesota

Event Categories
Keywords: pharmaceutical , bioengineering


Events Calendar

1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4


VIP Life Time Subscription to our Newsletters!